Clinical significance of mismatch repair gene expression in sporadic colorectal cancer

Experimental and Therapeutic Medicine

Volumn 8, Issue 5, 2014, Pages 1416-1422

  Sun, Zhenqiang ^a,b   Yu, Xianbo ^a   Wang, Haijiang ^a   Zhang, Shuo ^a   Zhao, Zeliang ^a   Xu, Ruiwei ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Clinicopathological parameters; Immunohistochemistry; Mismatch repair genes; Prognosis; Sporadic colorectal cancer

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ABERRANT EXPRESSION; ADULT; AGE; ANEMIA; ARTICLE; BODY MASS; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; COLLOID CARCINOMA; COLORECTAL CANCER; COLORECTAL MUCOSA; DISEASE FREE SURVIVAL; FAMILY HISTORY; FEMALE; FOLLOW UP; GENDER; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; MISMATCH REPAIR GENE; MUCOSA; PROTEIN EXPRESSION; SPORADIC COLORECTAL CANCER; TUMOR VOLUME;

EID: 84907812990     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1927     Document Type: Article

References (49)

1. Adib SM, Tabbal N, Hamadeh R and Ammar W: Geographic epidemiology in a small area: cancer incidence in Baakline, Lebanon, 2000-2008. East Mediterr Health J 19: 320-326, 2013.
2. Van Engeland M, Derks S, Smits KM, et al: Colorectal cancer epigenetics: complex simplicity. J Clin Oncol 29: 1382-1391, 2011.
3. Blokhuis MM, Pietersen GE, Goldberg PA, et al: Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters. Fam Cancer 9: 357-363, 2010.
4. Fishel R, Lescoe MK, Rao MR, et al: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027-1038, 1993.
5. Aaltonen LA, Salovaara R, Kristo P, et al: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338: 1481-1487, 1998.
6. Mureşan F, Simescu R, Domşa I, et al: Immunohistochemical screening of hMLH1 and hMSH2 gene mutations in patients diagnosed with colorectal cancer and microsatellite instability suspicion. Chirurgia (Bucur) 106: 775-780, 2011 (In Romanian).
7. Wei W, Liu F, Liu L, et al: Distinct mutations in MLH1 and MSH2 genes in hereditary non-polyposis colorectal cancer (HNPCC) families from China. BMB Rep 44: 317-322, 2011.
8. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89: 1758-1762.
9. Lynch HT and Smyrk T: Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 78: 1149-1167, 1996.
10. Aung Ko Win, Joanne P Young, et al: Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol 30: 958-964, 2012.
11. Wada-Hiraike O, Yano T, Nei T, et al: The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor alpha. Br J Cancer 92: 2286-2291, 2005.
12. Park IJ, Kim HC, Kim JS, et al: Correlation between hhMLH1/hhMSH2 and p53 protein expression in sporadic colorectal cancer. Hepatogastroenterology 52: 450-454, 2005.
13. Vreeswijk MP and van der Klift HM: Analysis and interpretation of RNA splicing alterations in genes involved in genetic disorders. Methods Mol Biol 867: 49-63, 2012.
14. Sun ZQ, Yu XB, Wang HJ, et al: Relationship between Aberrant Expression of hMSH2 and prognosis in patients with sporadic colorectal cancer. Canc Cell Rec 2: e47-e54, 2014.
15. Belcheva A, Irrazabal T, Robertson SJ, et al: Gut microbial metabolism drives transformation of msh2-deficient colon epithelial cells. Cell 158: 288-299, 2014.
16. Cunningham JM, Kim CY, Chirstensen ER, et al: The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 69: 780-790, 2001.
17. Ionov Y, Peinado MA, Malkhosyan S, et al: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561, 1993.
18. Popat S, Hubner R and Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23: 609-618, 2005.
19. Ribic CM, Sargent DJ, Moore MJ, et al: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349: 247-257, 2003.
20. Sargent DJ, Marsoni S, Monges G, et al: Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 28: 3219-3226, 2010.
21. Holzhüter J, Rösch T, Block A, et al: A 44-year-old woman with hereditary nonpolyposis colon carcinoma: screening examinations for non-colonic tumors. Internist (Berl) 54: 353-358, 2013 (In German).
22. Plevová P, Krepelová A, Papezová M, et al: Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer. Neoplasma 51: 275-284, 2004.
23. Lindor NM, Burgart LJ, Leontovich O, et al: Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 20: 1043-1048, 2002.
24. Ruszkiewicz A, Bennett G, Moore J, et al: Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 34: 541-547, 2002.
25. Shia J, Klimstra DS, Nafa K, et al: Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 29: 96-104, 2005.
26. Marcus VA, Madlensky L, Gryfe R, et al: Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 23: 1248-1255, 1999.
27. Joost P, Veurink N, Holck S, et al: Heterogenous mismatch-repair status in colorectal cancer. Diagn Pathol 9: 126, 2014.
28. Haghighi MM, Aghagolzadeh P, Zadeh SM, et al: Telomere shortening: a biological marker of sporadic colorectal cancer with normal expression of p53 and mismatch repair proteins. Genet Test Mol Biomarkers 18: 236-244, 2014.
29. Hawkins NJ and Ward RL: Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 93: 1307-1313, 2001.
30. Kupčinskaitė-Noreikienė R, Skiecevičienė J, Jonaitis L, et al: CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues. Medicina (Kaunas) 49: 361-366, 2013.
31. Gomes A, Reis-Silva M, Alarcão A, et al: Promoter hypermethylation of DNA repair genes MLH1 and MSH2 in adenocarcinomas and squamous cell carcinomas of the lung. Rev Port Pneumol 20: 20-30, 2014.
32. Molaei M, Mansoori BK, Ghiasi S, et al: Colorectal cancer in Iran: immunohistochemical profiles of four mismatch repair proteins. Int J Colorectal Dis 25: 63-69, 2010.
33. Bellizzi AM and Frankel WL: Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol 16: 405-417, 2009.
34. Valle L, Perea J, Carbonell P, et al: Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 25: 781-786, 2007.
35. Jass JR: HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Fam Cancer 3: 93-100, 2004.
36. Raskin GA, Ianus GA, Kornilov AV, et al: Immunohistochemical examination of MSH2, PMS2, MLH1, MSH6 compared with the analysis of microsatellite instability in colon adenocarcinoma. Vopr Onkol 60: 47-50, 2014 (In Russian).
37. Kim JH and Kang GH: Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer. World J Gastroenterol 20: 4230-4243, 2014.
38. Goldstein J, Tran B, Ensor J, et al: Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol 25: 1032-1038, 2014.
39. Slattery ML, Levin TR, Ma K, et al: Family history and colorectal cancer: predictors of risk. Cancer Causes Control 14: 879-887, 2003.
40. Campbell PT, Cotterchio M, Dicks E, et al: Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer. Cancer Epidemiol Biomarkers Prev 16: 1735-1744, 2007.
41. van Duijnhoven FJ, Botma A, Winkels R, et al: Do lifestyle factors influence colorectal cancer risk in Lynch syndrome? Fam Cancer 12: 285-293, 2013.
42. Botma A, Nagengast FM, Braem MG, et al: Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. J Clin Oncol 28: 4346-4353, 2010.
43. Win AK, Dowty JG, English DR, et al: Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Br J Cancer 105: 162-169, 2011.
44. Sánchez-de-Abajo A, de la Hoya M, van Puijenbroek M, et al: Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways. Clin Cancer Res 13: 5729-5735, 2007.
45. Karoui M, Tresallet C, Brouquet A, et al: Colorectal carcinogenesis. 1. Hereditary predisposition and colorectal cancer. J Chir (Paris) 144: 13-18, 2007 (In French).
46. Bubb VJ, Curtis LJ, Cunningham C, et al: Microsatellite instability and the role of hhMSH2 in sporadic colorectal cancer. Oncogene 12: 2641-2649, 1996.
47. Gryfe R, Kim H, Hsieh ET, et al: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342: 69-77, 2000.
48. Sankila R, Aaltonen LA, Järvinen HJ and Mecklin JP: Better survival rates in patients with hMLH1-associated hereditary colorectal cancer. Gastroenterology 110: 682-687, 1996.
49. Heinimann K, Scott RJ, Buerstedde JM, et al: Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer. Cancer 85: 2512-2518, 1999.